Cervical preparation prior to dilation and evacuation between 13 and 16 weeks gestation

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Surgical Procedures

Background:

• Cervical preparation is crucial for safe and efficient dilation and evacuation (D&E).
• Various single-agent methods, including buccal misoprostol, oral mifepristone, and osmotic dilators, are used prior to D&E.
• Understanding the comparative outcomes of these agents is essential for clinical practice.

Purpose of the Study:

• To compare the procedural outcomes of single-agent cervical preparation methods for D&E.
• To evaluate differences in procedure time and complications associated with buccal misoprostol, oral mifepristone, and osmotic dilators.
• To inform clinical decision-making regarding cervical preparation for D&E.

Main Methods:

• Retrospective cohort study of 277 patients undergoing D&E between 13 to 16 weeks gestation.
• Comparison of outcomes following cervical preparation with buccal misoprostol, oral mifepristone, or osmotic dilators.
• Primary outcome: procedure time; Secondary outcomes: procedure complications and estimated blood loss (EBL).

Main Results:

• No significant differences in adjusted procedure time were observed among the three cervical preparation methods (p=0.11).
• Oral mifepristone was associated with a trend towards lower estimated blood loss (EBL), though not clinically significant.
• All methods demonstrated a low incidence of procedure complications.

Conclusions:

• Buccal misoprostol, oral mifepristone, and osmotic dilators are all effective for cervical preparation prior to D&E, associated with short procedure times and minimal complications.
• The choice of cervical preparation method for D&E can be tailored to individual patient preferences and specific clinical needs.
• Further research may explore subtle differences in EBL or patient-reported outcomes.